[1] NORTHWAY W H Jr,ROSAN R C,PORTER D Y.Pulmonary disease following respirator therapy of hyaline-membrane disease.Bronchopulmonary dysplasia[J].N Engl J Med,1967,276(7):357-368.
[2] 张家云,江魁明,董天发,等.早产儿支气管肺发育不良的X线表现[J].实用放射学杂志,2009,25(12):1807-1809.
[3] TOCE S S,FARRELL P M,LEAVITT L A,et al.Clinical and roentgenographic scoring systems for assessing bronchopulmonary dysplasia[J].Am J Dis Child,1984,138(6):581-585.
[4] VAN M E,LOGIE K,CIET P,et al.Lung CT imaging in patients with bronchopulmonary dysplasia:a systematic review[J].Pediatr Pulmonol,2016,51(9):975-986.
[5] 赵宝英,卫宏江,郝哲,等.肺高分辨率CT"马赛克"衰减与肺功能的相关性研究[J].放射学实践,2003,18(7):479-482.
[6] SEMPLE T,AKHTAR M R,OWENS C M.Imaging bronchopulmonary dysplasia-a multimodality update[J].Front Med,2017,4:88.
[7] BHANDARI A,MCGRATH-MORROW S.Long-term pulmonary outcomes of patients with bronchopulmonary dysplasia[J].Semin Perinatol,2013,37(2):132-137.
[8] WALKUP L L,TKACH J A,HIGANO N S,et al.Quantitative magnetic resonance imaging of bronchopulmonary dysplasia in the neonatal intensive care unit environment[J].Am J Respir Crit Care Med,2015,192(10):1215-1222.
[9] CLARISSA H P,JOHAN S,ESTHER J B.The value of ultrasound examination of the lungs in predicting bronchopulmonary dysplasia[J].Pediatr Radiol,2004,34(3):227-231.
[10] KROHN B G.Effect of inhaled nitric oxide on left ventricular and pulmonary vascular function (letter)[J].J Thoracic Cardiovasc Surg,1999,117(1):195-196.
[11] CZERNIK C,RHODE S,METZE B,et al.Persistently elevated right ventricular index of myocardial performance in preterm infants with incipient bronchopulmonary dysplasia[J].PLoS One,2012,7(6):e38352.
[12] LAL C V,AMBALAVANAN N.Biomarkers,early diagnosis,and clinical predictors of bronchopulmonary dysplasia[J].Clin Perinatol,2015,42(4):739-754.
[13] SCHRAMA A J J,BERNARD A,POORTHUIS B J H M,et al.Cord blood Clara cell protein CC16 predicts the development of bronchopulmonary dysplasia[J].Eur J Pediatr,2008,167(11):1305-1312.
[14] 梁莹莹,邹卉,韩梅盈,等.支气管肺发育不良早产儿生后早期外周血清CC16变化的意义[J].中国新生儿科杂志,2016,11(5):364-366.
[15] 罗英,高平明,戴怡蘅,等.血清胰岛素生长因子-1与支气管肺发育不良的相关性研究[J].中国临床医生杂志,2015(7):86-88.
[16] YANG J Y,CHA J,SHIM S Y,et al.The relationship between eosinophilia and bronchopulmonary dysplasia in premature infants at less than 34 weeks' gestation[J].Korean J Pediatr,2014,57(4):171-177.
[17] KANDASAMY J,ROANE C,SZALAI A,et al.Serum eotaxin-1 is increased in extremely-low-birth-weight infants with bronchopulmonary dysplasia or death[J].Pediatr Res,2015,78(5):498-504.
[18] HUAUX F,GHARAEEKERMANI M,LIU T,et al.Role of Eotaxin-1(CCL11) and CC chemokine receptor 3(CCR3) in bleomycin-induced lung injury and fibrosis[J].Am J Pathol,2005,167(6):1485-1496.
[19] JAMALUDDIN M S,WANG X,HAO W,et al.Eotaxin increases monolayer permeability of human coronary artery endothelial cells[J].Arterioscler Thromb Vasc Biol,2009,29(12):2146-2152.
[20] 高原,林振浪,陈尚勤.基质金属蛋白酶与支气管肺发育不良[J].中华新生儿科杂志,2011,26(1):53-56.
[21] FUKUNAGA S,ICHIYAMA T,MAEBA S,et al.MMP-9 and TIMP-1 in the cord blood of premature infants developing BPD[J].Pediatr Pulmonol,2010,44(3):267-272.
[22] 金蕊,卢红艳,罗妍妍,等.尿半胱氨酸白三烯E4诊断支气管肺发育不良的临床评价[J].中华儿科杂志,2016,54(9):703-707.
[23] SUNDAY M E,YODER B A,CUTTITTA F,et al.Bombesin-like peptide mediates lung injury in a baboon model of bronchopulmonary dysplasia[J].J Clin Invest,1998,102(3):584-594.
[24] SUBRAMANIAM M,SUGIYAMA K,COY D H,et al.Bombesin-like peptides and mast cell responses:relevance to bronchopulmonary dysplasia?[J].Am J Respir Crit Care Med,2003,168(5):601-611.
[25] JOUNG K E,KIM H S,LEE J,et al.Correlation of urinary inflammatory and oxidative stress markers in very low birth weight infants with subsequent development of bronchopulmonary dysplasia[J].Free Radic Res,2011,45(9):1024-1032.
[26] TOKURIKI S,OKUNO T,OHTA G,et al.Carboxyhemoglobin formation in preterm infants is related to the subsequent development of bronchopulmonary dysplasia[J].Dis Markers,2015,2015:620921.
[27] HSIAO C C,CHANG J C,TSAO L Y,et al.Correlates of elevated interleukin-6 and 8-hydroxy-2'-deoxyguanosine levels in tracheal aspirates from very low birth weight infants who develop bronchopulmonary dysplasia[J].Pediatr Neonatol,2017,58(1):63-69.
[28] SCHNEIBEL K R,FITZPATRICK A M,PING X D,et al.Inflammatory mediator patterns in tracheal aspirate and their association with bronchopulmonary dysplasia in very low birth weight neonates[J].J Perinatol,2013,33(5):383-387.
[29] RAMSAY P L,DEMAYO F J,HEGEMIER S E,et al.Clara cell secretory protein oxidation and expression in premature infants who develop bronchopulmonary dysplasia[J].Am J Respir Crit Care Med,2001,164(1):155-161.
[30] GUZMÁNBÁRCENAS J,CALDERÓNMOORE A,BAPTISTAGONZÁLEZ H,et al.Clara cell protein expression in mechanically ventilated term and preterm infants with respiratory distress syndrome and at risk of bronchopulmonary dysplasia:a pilot study[J].Can Respir J,2017,2017(9):8074678.
[31] SHAWN K A,JIAN W,YONG G,et al.Initial suppression of transfor ming growth factor-β signaling and loss of TGFBI causes early alveolar structural defects resulting in bronchopulmonary dysplasia[J].Am J Pathol,2016,186(4):777-793.
[32] ZHANG L,JI Y,KANG Z,et al.Protocatechuic aldehyde ameliorates experimental pulmonary fibrosis by modulating HMGB1/RAGE pathway[J].Toxicol Appl Pharmacol,2015,283(1):50-56.
[33] 程红斌.支气管肺发育不良新生儿肺灌洗液HMGB1和TGF-β的改变及临床意义[J].中国实验诊断学,2016,20(6):991-993.
[34] HENDRICKSMUÑOZ K D,XU J,VOYNOW J A.Tracheal aspirate VEGF and sphingolipid metabolites in the preterm infant with later development of bronchopulmonary dysplasia[J].Pediatr Pulmonol,2018,53(8):1046-1052.
[35] QUATTRONE A,MAZZEI R.Cysteine-sparing notch3 mutations:cadasil or cadasil variants?[J].Neurology,2009,72(24):2135-2136.
[36] MACHUCAPARRA A I,BIGGERALLEN A A,SANCHEZ A V,et al.Therapeutic antibody targeting of Notch3 signaling prevents mural cell loss in CADASIL[J].J Exp Med,2017,214(8):2271-2282.
[37] 陈颖,张金凤,麦丽珊,等.早产儿血液中Notch 3的变化对支气管肺发育不良早期诊断价值的研究[J].中国当代医药,2018(1):82-84.
[38] GURSOY T,HAYRAN M,DERIN H,et al.A clinical scoring system to predict the development of bronchopulmonary dysplasia[J].Am J Perinatol,2015,32(7):659-666.
[39] BARALDI E,GIORDANO G,STOCCHERO M,et al.Untargeted metabolomic analysis of amniotic fluid in the prediction of preterm delivery and bronchopulmonary dysplasia[J].PLoS One,2016,11(10):e0164211.
[40] BERNHARD W,RAITH M,KOCH V,et al.Developmental changes in polyunsaturated fetal plasma phospholipids and feto-maternal plasma phospholipid ratios and their association with bronchopulmonary dysplasia[J].Eur J Nutr,2016,55(7):2265-2274.
[41] OBER C,TAN Z,SUN Y,et al.Effect of variation in CHI3L1 on serum YKL-40 level,risk of asthma,and lung function[J].N Engl J Med,2008,358(16):1682-1691.
[42] WANG X,LI W,LIU W,et al.GSTM1 and GSTT1 gene polymorphisms as major risk factors for bronchopulmonary dysplasia in a Chinese Han population.[J].Gene,2014,533(1):48-51.
[43] ROBBINS M E,DAKHLALLAH D,MARSH C B,et al.Of mice and men:correlations between microRNA-17~92 cluster expression and promoter methylation in severe bronchopulmonary dysplasia[J].Am J Physiol Lung Cell Mol Physiol,2016,311(5):L981-L984.
[44] VENKATESH S,JEFFERY S G,DANIEL H,et al.Antioxidant response genes sequence variants and BPD susceptibility in VLBW infants[J].Pediatr Res,2015,77(3):477-483. |
